Entero Therapeutics Statistics Share Statistics Entero Therapeutics has 4.77M
shares outstanding. The number of shares has increased by 46.49%
in one year.
Shares Outstanding 4.77M Shares Change (YoY) 46.49% Shares Change (QoQ) 0.25% Owned by Institutions (%) n/a Shares Floating 4.44M Failed to Deliver (FTD) Shares 2,366 FTD / Avg. Volume 0.18%
Short Selling Information The latest short interest is 286.6K, so 6.01% of the outstanding
shares have been sold short.
Short Interest 286.6K Short % of Shares Out 6.01% Short % of Float 6.01% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.16 and the forward
PE ratio is -0.28.
Entero Therapeutics's PEG ratio is
0.
PE Ratio -0.16 Forward PE -0.28 PS Ratio 0 Forward PS 0 PB Ratio 0.05 P/FCF Ratio -0.31 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Entero Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.03,
with a Debt / Equity ratio of 0.
Current Ratio 3.03 Quick Ratio 3.03 Debt / Equity 0 Debt / EBITDA -9 Debt / FCF -0.02 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-9.03M Employee Count 2 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -50.45% in the
last 52 weeks. The beta is 0.84, so Entero Therapeutics's
price volatility has been higher than the market average.
Beta 0.84 52-Week Price Change -50.45% 50-Day Moving Average 0.44 200-Day Moving Average 0.5 Relative Strength Index (RSI) 62.33 Average Volume (20 Days) 1,313,396
Income Statement
Revenue n/a Gross Profit n/a Operating Income -15.62K Net Income -18.06M EBITDA -15.61K EBIT -15.62K Earnings Per Share (EPS) -3.88
Full Income Statement Balance Sheet The company has 163.48K in cash and 140.53K in
debt, giving a net cash position of 22.94K.
Cash & Cash Equivalents 163.48K Total Debt 140.53K Net Cash 22.94K Retained Earnings -202.39M Total Assets 85.2M Working Capital 54.72M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -9.22M
and capital expenditures 0, giving a free cash flow of -9.22M.
Operating Cash Flow -9.22M Capital Expenditures n/a Free Cash Flow -9.22M FCF Per Share -1.98
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ENTO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ENTO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Dec 18, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Dec 18, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -2.82 Piotroski F-Score 3
